Sickle cell disease, a chronic debilitating disorder, is characterized by ongoing hemolytic anemia, vaso-occlusive events, and progressive organ damage.
Moniba Nazeef, MD
Advertisement
Articles by Moniba Nazeef, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Tucatinib Plus Trastuzumab/Pertuzumab as First-Line Maintenance in Advanced HER2+ Breast Cancer
2
GI Cancer Monthly Rewind: Key News and Expert Insights You May Have Missed in September 2026
3
FDA Grants Breakthrough Device Designation to Natera’s Multi-Cancer Early Detection Assay
4
Five Under 5: Top Oncology Videos for the Week of 10/5/2026
5